Stent expansion in calcified coronary chronic total occlusions:  The impact of different stent platforms

To evaluate the stent expansion of the durable‐polymer Zotarolimus‐eluting stent (dp‐ZES), the durable‐polymer Everolimus‐eluting stent (dp‐EES), and the bioabsorbable‐polymer Sirolimus‐eluting stent (bp‐SES) in calcified coronary chronic total occlusions (CTO).

[1]  A. Roguin,et al.  Ultrathin Bioresorbable Polymer Sirolimus-Eluting Stents Versus Durable Polymer Everolimus-Eluting Stents: BIOFLOW V Final 5-Year Outcomes. , 2022, JACC. Cardiovascular interventions.

[2]  J. Henriques,et al.  Very long-term outcome of the PRISON-IV trial: 5-year clinical follow-up of ultra-thin struts in CTO-PCI. , 2022, Cardiovascular revascularization medicine : including molecular interventions.

[3]  K. Akazawa,et al.  Predictors and outcomes of acute recoil after ultrathin bioresorbable polymer sirolimus-eluting stents implantation: an intravascular ultrasound in native coronary arteries , 2021, Coronary artery disease.

[4]  F. Zijlstra,et al.  Elastic stent recoil in coronary total occlusions: Comparison of durable‐polymer zotarolimus eluting stent and ultrathin strut bioabsorbable‐polymer sirolimus eluting stent , 2021, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[5]  R. Virmani,et al.  Definitions and Clinical Trial Design Principles for Coronary Artery Chronic Total Occlusion Therapies: CTO-ARC Consensus Recommendations. , 2021, Circulation.

[6]  A. Roguin,et al.  Ultrathin Bioresorbable-Polymer Sirolimus-Eluting Stents Versus Thin Durable-Polymer Everolimus-Eluting Stents for Coronary Revascularization: 3-Year Outcomes From the Randomized BIOFLOW V Trial. , 2020, JACC. Cardiovascular interventions.

[7]  M. Stoel,et al.  Thin, Very Thin, or Ultrathin Strut Biodegradable- or Durable-Polymer-Coated Drug-Eluting Stents: 3-Year Outcomes of BIO-RESORT. , 2019, JACC. Cardiovascular interventions.

[8]  J. Tijssen,et al.  3-Year Clinical Outcomes of the PRISON-IV Trial: Ultrathin Struts Versus Conventional Drug-Eluting Stents in Total Coronary Occlusions. , 2019, JACC. Cardiovascular interventions.

[9]  N. Bozinovic,et al.  Percutaneous recanalisation of chronic total occlusions: 2019 consensus document from the EuroCTO Club. , 2019, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[10]  C. Di Mario,et al.  Derivation and Validation of a Chronic Total Coronary Occlusion Intervention Procedural Success Score From the 20,000-Patient EuroCTO Registry: The EuroCTO (CASTLE) Score. , 2019, JACC. Cardiovascular interventions.

[11]  M. Stoel,et al.  Two-year clinical outcome of all-comers treated with three highly dissimilar contemporary coronary drug-eluting stents in the randomised BIO-RESORT trial. , 2018, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[12]  M. Stoel,et al.  Thin composite wire strut, durable polymer-coated (Resolute Onyx) versus ultrathin cobalt–chromium strut, bioresorbable polymer-coated (Orsiro) drug-eluting stents in allcomers with coronary artery disease (BIONYX): an international, single-blind, randomised non-inferiority trial , 2018, The Lancet.

[13]  Mickael Bonin,et al.  Standardized bench test evaluation of coronary stents: Biomechanical characteristics , 2018, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[14]  E. Mahmud,et al.  Prevalence, Presentation and Treatment of ‘Balloon Undilatable’ Chronic Total Occlusions: Insights from a Multicenter US Registry , 2018, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[15]  Akiko Maehara,et al.  In Vivo Calcium Detection by Comparing Optical Coherence Tomography, Intravascular Ultrasound, and Angiography. , 2017, JACC. Cardiovascular imaging.

[16]  S. Miura,et al.  In-Stent Restenosis due to Stent Recoil After Third-Generation Drug-Eluting Stent Implantation , 2017, Journal of clinical medicine research.

[17]  J. Tijssen,et al.  Randomized Multicenter Trial Investigating Angiographic Outcomes of Hybrid Sirolimus-Eluting Stents With Biodegradable Polymer Compared With Everolimus-Eluting Stents With Durable Polymer in Chronic Total Occlusions: The PRISON IV Trial. , 2017, JACC. Cardiovascular interventions.

[18]  K. Isaaz,et al.  Restenosis after percutaneous coronary intervention for coronary chronic total occlusion. The central role of an optimized immediate post-procedural angiographic result. , 2016, International journal of cardiology.

[19]  C. Di Mario,et al.  Over-expansion capacity and stent design model: An update with contemporary DES platforms. , 2016, International journal of cardiology.

[20]  Masataka Nakano,et al.  Comparison of pathology of chronic total occlusion with and without coronary artery bypass graft. , 2014, European heart journal.

[21]  G. Stone,et al.  Coronary artery calcification: pathogenesis and prognostic implications. , 2014, Journal of the American College of Cardiology.

[22]  R. Whitbourn,et al.  Comparison of in vivo acute stent recoil between the bioresorbable everolimus‐eluting coronary scaffolds (revision 1.0 and 1.1) and the metallic everolimus‐eluting stent , 2011 .

[23]  Y. Hayashi,et al.  Predicting successful guidewire crossing through chronic total occlusion of native coronary lesions within 30 minutes: the J-CTO (Multicenter CTO Registry in Japan) score as a difficulty grading and time assessment tool. , 2011, JACC. Cardiovascular interventions.

[24]  R. Stables,et al.  Stent expansion: a combination of delivery balloon underexpansion and acute stent recoil reduces predicted stent diameter irrespective of reference vessel size , 2006, Heart.

[25]  G. Stone,et al.  Clinical researchInterventional cardiologyStent underexpansion and residual reference segment stenosis are related to stent thrombosis after sirolimus-eluting stent implantation: An intravascular ultrasound study , 2005 .

[26]  M. Leon,et al.  Patterns of calcification in coronary artery disease. A statistical analysis of intravascular ultrasound and coronary angiography in 1155 lesions. , 1995, Circulation.